The biology and physiology of ‘Nolvadex’ (tamoxifen) in the treatment of breast cancer
- 1 December 1982
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 2 (4), 363-374
- https://doi.org/10.1007/bf01805878
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Oestrogen receptor assay—Limitation of the methodEuropean Journal of Cancer (1965), 1981
- Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stabilityBritish Journal of Cancer, 1981
- Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. workshop, held on 16–17 March, 1979, in the Netherlands Cancer InstituteEuropean Journal of Cancer (1965), 1980
- Triple hormone-receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer?British Journal of Cancer, 1979
- Oestrogen receptors and the response to endocrine therapy in advanced breast cancerBritish Journal of Cancer, 1978
- Measurement of oestradiol receptors by five institutions on common tissue samplesBritish Journal of Cancer, 1978
- Effect of antiestrogen therapy on human mammary carcinomas with different estrogen receptor contentsEuropean Journal of Cancer (1965), 1978
- Tamoxifen (Antiestrogen) Therapy in Advanced Breast CancerAnnals of Internal Medicine, 1977
- Assessment of response to therapy in advanced breast cancerEuropean Journal of Cancer (1965), 1977
- Standards for the assessment of estrogen receptors in human breast cancerReport of a workshop on September 29, 1972, at the Antoni van Leeuwenhoek-Huis, AmsterdamEuropean Journal of Cancer (1965), 1973